GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » BiVictriX Therapeutics PLC (LSE:BVX) » Definitions » FFO

BiVictriX Therapeutics (LSE:BVX) FFO


View and export this data going back to 2021. Start your Free Trial

What is BiVictriX Therapeutics FFO?

FFO (Funds from operations) only applies to REITs.


BiVictriX Therapeutics Business Description

Traded in Other Exchanges
N/A
Address
Alderley Edge, Mereside, Alderley Park, Macclesfield, GBR, SK10 4TG
BiVictriX Therapeutics PLC is a drug development company. It has developed its proprietary Bi-Cygni technology which utilizes Antibody Drug Conjugates for the treatment of various cancers including Acute Myeloid Leukaemia. The Group has one reportable segment, being the development of pharmaceutical products within the United Kingdom.